Table 1.

Characteristics of tirofiban.

Drug name	Tirofiban
Chemical structure
Chemical name	N-(butylsulfonyl)-O-[4- (4-piperidinyl)butyl]-L-tyrosine
Substance type	Non-peptide
Inhibition modality	Selective competitive
Binding modality	Reversible
Route of administration	Intravenous
Onset	>90% inhibition of platelet aggregation seen within 10 min
Distribution	Vdss: 22–42 L
Protein Binding	65%
Plasma Half-life	2h
Platelet function recovery time	4–8 h after discontinuation
Excretion	Urine (65%) and feces (25%) primarily as unchanged tirofiban